CN102921068A - Cerebral infarction disease therapeutic apparatus - Google Patents
Cerebral infarction disease therapeutic apparatus Download PDFInfo
- Publication number
- CN102921068A CN102921068A CN2012104021972A CN201210402197A CN102921068A CN 102921068 A CN102921068 A CN 102921068A CN 2012104021972 A CN2012104021972 A CN 2012104021972A CN 201210402197 A CN201210402197 A CN 201210402197A CN 102921068 A CN102921068 A CN 102921068A
- Authority
- CN
- China
- Prior art keywords
- cerebral infarction
- therapeutic apparatus
- treatment
- friction head
- casing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
The invention discloses a cerebral infarction disease therapeutic apparatus which combines extrusion friction heating, mechanical massage and a medicine syringe. According to the cerebral infarction disease therapeutic apparatus, an extrusion friction head, a fixed friction head and a syringe are arranged in a therapeutic apparatus shell in parallel in a staggered manner; the therapeutic apparatus is aligned to a part with a diminished function of a patient, and mechanical energy, heat energy and chemical energy are input into the body to perform function recovery treatment. According to the cerebral infarction disease therapeutic apparatus, the function of a human body is considered to be mainly mechanical energy and heat energy, but energy shortage and function diminishing have appeared at a soft silk weaving part around a vascular injury lesion of a cerebral infarction patient and are the reasons for difficulty in curing of the patient and death. In a critical period of acute attack of cerebral infarction, the function recovery treatment is performed by treating both symptoms and root causes; the cerebral infarction disease therapeutic apparatus and anti-injury treatment of the prior art promote mutually and act together; and through integral treatment, the goal of reducing the disability rate and the death rate of the cerebral infarction is achieved.
Description
Technical field
The invention belongs to medical apparatus and instruments, more particularly is to belong to the cerebral infarction disease therapeutic apparatus that extrusion friction, static friction, drug injection are combined as a whole.
Background technology
Cerebral infarction refers to because cerebrovascular Serious Stenosis or obturation, cerebral blood supply obstacle cause the cerebral blood flow blocking-up, cause cerebral tissue ischemia, anoxia and necrose, the softening cerebrovascular disease that forms infarction, account for the 50%-60% of all acute cerebrovascular, comprising the hemorrhagic cerebral infarction due to being formed by cerebral embolism and cerebral venous thrombosis.On the Chinese medicine cerebral infarction is called apoplexy, thinks that blood stasis due to qi deficiency is the common disease of suffering from acute stroke, in acute stage take blood stasis as main, convalescent period take the deficiency of vital energy as main.Many patients with cerebrovascular disease are all died from acute stage in the clinical treatment, and the main cause of death all is life-threatening complication.
Prior art is owing to the globality understanding that lacks things, in the cerebral infarction disease acute stages treated, mainly be to adopt medicines such as expanding blood vessel, blood pressure lowering, dehydration, the blood vessel structure pathological changes is treated, and lack the treatment of makeup energy restore funcitons, approximately just carry out the rehabilitation of restore funcitons after acute stage about ten days in pathological changes.
" equipment for treating cardiovascular and cerebrovascular diseases " ZL2006100695538, December obtained national inventing patent on the 8th in 2010, therapy of serious disease principle and method have been proposed in patent specification, think that it is the essence of major disease that structural damage and function reduction restrict the whole pathological changes of generation mutually, the whole factor that is dyadic interaction plays a decisive role, rather than some factors.Major disease is to carry out change of illness state all the time with globality, regardless of order of importance and emergency variation in the pathological process, all is the result of dyadic interaction, does not have discerptible change procedure.Because orientation treatment is indefinite, prior art can not significantly reduce cerebral infarction disease disability rate, case fatality rate.
Aspect treatment technology, mention in " equipment for treating cardiovascular and cerebrovascular diseases " patent specification: heat the treatment cerebrovascular disease that combines in the cerebral embolism focus topical remedy injection that Japan carries out with ultrasound wave, owing to lacking mechanical massage, can not solve muscle rigidity blood microcirculation obstacle, ultra sonic machinery active force relative deficiency, therapeutic effect is limited, can not obtain remarkable result.
Summary of the invention
Purpose of the present invention, be that fixedly static friction head, injection of drug device, casing, switch junctions are synthesized whole with micro machine fixed press friction head, micro machine, muscular tissue around the cerebrovascular trauma is carried out restore funcitons to etiological treatment, with prior art cerebrovascular trauma medicine symptomatic treatment is combined, cerebral infarction disease is carried out wholistic therapy, to reach the target of remarkable reduction disability rate, case fatality rate.
To achieve the above object of the invention, the present invention is with extrusion friction head, static friction head, injection for curing device, casing, the synthetic wholistic therapy device of switch junctions.It is characterized in that: with extrusion friction head, static friction parallel staggered being installed in the casing, the injection for curing device is by being placed on center injection through hole in the casing, on the casing by switch is housed.Hold therapeutic apparatus during treatment and gently press therapentic part, injection for curing device inner liquid medicine is injected in the body, starting switch pivoting friction head carries out frictional heat, rubs, absorbs Drug therapy.
The below is described below treatment principle of the present invention and treatment characteristics respectively:
One, treatment philosophy and technique of the present invention
1, restore funcitons treatment principle: human life is the integral body of the symmetrical equivalent mutual dependence for existence facilitation of structure function, is the senior forms of motion of the symmetrical equivalent mutual dependence for existence facilitation of physical chemistry.Metabolic function is the basis that life exists, and each step reaction of substance metabolism all is accompanied by the transfer of energy, and it is inseparable that blood and muscle in the human life, microcirculation and body circulation, structure and function closely link to each other, and moves according to global regularity.
Shown in " disease produces the developmental principle schematic diagram " in therapy of serious disease principle and the method: the cerebral infarction pathological changes is that cerebrovascular organ structure damage pathological changes and cerebrovascular system function decline restrict due to the mass action mutually, next step of its development is exactly cerebrovascular system structural damage pathological changes, mutually restrict with the Whole Body function reduction, cause death.As long as but carry out the restore funcitons treatment, also can be dead though the existence of patient's function is seriously ill.Make a gift of described in " medical science source and course note " such as the physician Xu Ling of the Qing Dynasty: " if vigour do not hinder, though disease is very not dead.Vigour or wound are though disease is gently also dead ".Modern medicine is owing to lacking whole understanding, can only carry out the level location to structure, can not carry out the level location to function, think that it is the structures shape function that both sides concern, cause the orientation treatment mistake, pathological changes acute stage shortage restore funcitons treatment at crux makes the anti-injury in treating of structure restricted by function reduction, can not reach therapeutic goal.During the cerebral infarction acute attack, adopt the wholistic therapy for the treatment of both the principal and secondary aspects of a disease, could control whole pathological changes.The wholistic therapy that the present invention adopts the symmetrical equivalence of the anti-damage of structure and restore funcitons to mutually promote reaches the target of remarkable reduction disability rate, case fatality rate.
2, function reduction pathological changes happening part
Human body is uprightly evolved, and to lack motion be the immediate cause that causes patient's musculi colli stiff to cervical region, and there is strength section muscle rigidity in most patients with cerebrovascular disease, is the immediate cause that disturbance of blood circulation produces.In the normal brain activity circulation, the both sides internal carotid artery accounts for 4/5 of full cerebral blood flow, and the left and right sides vertebral artery accounts for about 1/5 of full cerebral blood flow.Cerebral atherosclerosis is main and common in the cerebrovascular, its predilection site is: common carotid artery furcation and bending section, carotid sinus section etc., prior art thinks that the generation of sclerosis is relevant with the blood flow impact, and the muscular tissue around the arteriosclerosis is exactly the function reduction position.
3, the character of function reduction and treatment
Blood vessel structure damage pathological changes when occuring in Patients with Cerebral Infarction, and infantile myasthenia is organized the function reduction pathological changes has also been occured around the blood vessel structure damage, microcirculation disturbance occurred.Microcirculatory resistance accounts for about 90% of whole circulation, the mechanical energy loss of microcirculation blood flow has determined the heart output, microcirculatory basic function is to realize mass exchange, in clinical treatment, the Drug therapy of the overwhelming majority is all delivered to the lesion by blood circulation by microcirculation and is played a role.So, the anti-injury in treating of structure and function reduction resume treatment of equal importance, should carry out simultaneously, it is indispensable that the blood microcirculation obstacle is eliminated in Patients with Acute Cerebral Infarction restore funcitons treatment, can not in time position the restore funcitons treatment and be cause that the patient is disabled, one of Factors of death.
Microcirculatory power resources are in muscular tissue mechanical movement on every side, simple heating, electrotherapy, medicine antihypertensive effect are limited, cervical region microcirculation disturbance and systemic blood flow increase, blood pressure does not have direct relation, because the blood capillary diameter does not have to feel a variation of looking into during blood pressure change, the rigidity 99% of blood capillary only has 1% to derive from interior epithelium and matrix membrane from surrounding tissue.Therefore, with regard to mechanical property, should regard blood capillary and surrounding tissue as whole.Extrusion friction of the present invention gives birth to that heat, static friction mechanically rub, drug injection, can make stiff muscular tissue loosen blood capillary unimpeded, blood flow increases 10-16 doubly, and the open number of blood capillary is increased to 1400 by 31 in every cubic millimeter, 7 times of lymph fluid flow faster, microcirculation disturbance is eliminated.Combine with prior art medicine dredging blood vessel dilating symptomatic treatment cerebral infarction, treating both the principal and secondary aspects of a disease reaches therapeutic goal.
Two, the Drug therapy among the present invention
" the activating blood and resolving stasis and treating vascular conditions such as thrombosis, angiorrhexis (in vivo hemorrhage, i.e. motherland's medical science so-called " blood circulating out of vessels "), vasospasm, also belong to blood stasis disease category, therefore all can adopt this method treatment.This law is multiplex in stroke rehabilitation phase treatment, but acute stage also can use, be used for the blood circulation promoting medicine of drastically removing blood stasis and resolving static blood, Ru Sanling, Rhizoma Curcumae, Semen Vaccariae, Squama Manis.Stage of attack,, hemorrhage, blood stasis, thrombosis formed, and in this stage, blood stasis is newly tied, and facilitation is easily dispelled, should be to dispel as main, it is auxiliary invigorating blood circulation, stopping blooding "." rescue of cerebrovascular and rehabilitation " People's Health Publisher the 1st edition Zhao Minglun chief editor in October nineteen ninety-five (188 pages-190 pages)
The external treatment expert Wu Shiji of the Qing Dynasty says in " Li Yue Pianwen, Rhymed Discourse for Topical Remedies ": " reason of external treatment is the reason for the treatment of by oral administration of medicines, the medicine of external treatment that is the medicine for the treatment of by oral administration of medicines ", external treatment can " walk abreast with treatment by oral administration of medicines, and can mend not capturing for the treatment of by oral administration of medicines ".Drug administration by injection among the present invention mainly is the soft tissue such as muscle around the vasoactive, and used pharmaceutical properties is identical with medicine in the prior art symptomatic treatment, comprises various Chinese medicines and Western medicine.
Three, technical characterstic of the present invention
According in therapy of serious disease principle and the method shown in " disease treatment philosophy and technique schematic diagram ": when the patient falls ill,---senior forms of motion pathological changes, the wholistic therapy that need to adopt naturopathy and chemotherapy to mutually promote---the senior forms of motion technology treatment that the whole pathological changes that physics pathological changes and chemical pathological changes restrict mutually occurred.
1, the bodily fuctions mainly is exactly mechanical energy and heat energy, and restore funcitons is exactly descend diseased region input mechanical energy and heat energy to the bodily fuctions.Static friction among a present invention rotating speed is 80 rev/mins, and pressure 1 kg/cm can be pressed stiff muscles and rubbed, and the loosening all muscles blood flow is increased.Extrusion friction head rotating speed is 300 rev/mins, and pressure 0.2 kg/cm can be carried out frictional heat at skin surface, and temperature reaches 50 ℃ within 10 seconds, carry heat energy in body.Two kinds of parallel staggered being installed in together of friction head when carrying out the naturopathy conveying capacity, absorb injectable drug, carry out the restore funcitons treatment.For minority severe disease feelings patient diseased region, can be by adjusting pressure, adjust therapentic part and adopting the less ultrasonic wave therapeutic apparatus of mechanicals efforts.
2, because treatment area in cerebral infarction pathological changes position is less, carry out the transdermal pharmaceutical amount limited, be not suitable for transdermal medicine for treating, therefore adopt drug injection of the prior art, particularly needleless drug injection.Because there is slight scar in skin surface behind the drug injection, can not rub rubs, so be provided with the special-purpose through hole of syringe in the therapeutic apparatus center, with the certain distance of friction head maintenance on every side, rubbing after having injected, it is unaffected to rub.
The present invention has been compared with the prior art following characteristics:
Structure and function are the whole relation of mutual dependence for existence in the human body, and each step reaction of structural change all is accompanied by energy and shifts.Cerebral infarction is the whole pathological changes that a kind of structural damage and function reduction restrict mutually, and prior art is only carried out anti-damage symptomatic treatment at cerebral infarction acute attack crux period, does not carry out restore funcitons to etiological treatment, is the limited main cause of curative effect.The present invention combines with anti-injury in treating by the restore funcitons treatment, can reach the therapeutic goal of remarkable reduction disability rate, case fatality rate.The prior art ultrasound wave can be treated cerebral infarction to the present invention and be carried out partner treatment, to improve curative effect, but ultrasound wave fails to form conventional treatment means, main cause is to can not determine suitable dosage, the mechanism of ultrasonic therapeutic is not clear, unclear is the result of local heat, still promotes the mobile role of body fluid.The ultrasonic therapy cerebral hemorrhage belongs to taboo in the prior art, produces mechanical shock massage and the effect of heating because ultrasonic acoustic pressure can be knitted 3-5 centimetre of deep, and active force is for cerebrovascular structural damage position, so can not be used for the cerebral hemorrhage symptom treatment.And depth of interaction of the present invention is between 1-4 centimetre, and the degree of depth can be regulated by pressure, when pressure 0.2 kg/cm, depth of interaction is 1 centimetre, active force is for cerebrovascular structural damage exterior circumferential muscular tissue, used medicine is identical with treatment by oral administration of medicines Bleeding control pharmaceutical properties, can play the Bleeding control effect, and can extend the expansion therapentic part.So during the cerebrovascular bleeding episodes, the restore funcitons treatment of input mechanical energy, heat energy, chemical energy can not stop.
Description of drawings
Fig. 1 is midbrain infarction disease treatment device front view of the present invention.
Fig. 2 be in the therapeutic apparatus shown in Figure 1 extrusion friction head A to view, a static friction B to view.
Fig. 3 is that extrusion friction head in the therapeutic apparatus shown in Figure 1, static friction head, syringe through hole assembling arrangement C are to view.
Fig. 4 is " disease produces the developmental principle schematic diagram ".
Fig. 5 is " disease treatment philosophy and technique schematic diagram ".
The specific embodiment
In the cerebral infarction disease therapeutic apparatus shown in Figure 1 of the present invention: the 1st, extrusion friction head, the 2nd, static friction head, the 3rd, syringe, the 4th, casing, the 5th, switch, the 6th, wire.
Therapeutic apparatus of the present invention is achieved through the following technical measures: a kind of cerebral infarction disease therapeutic apparatus, the integral body that it is comprised of extrusion friction head, static friction head, syringe, casing, switch, wire, cerebral infarction disease function reduction diseased region is carried out frictional heat, treats by rubbing up the drug injection restore funcitons, combine the wholistic therapy cerebral infarction disease with the anti-damage medicine symptomatic treatment of prior art; It is characterized in that: extrusion friction head (1) staggered be installed in casing (4) in parallel with static friction head (2), by putting, switch (5) is installed on the casing (4) syringe (3) by casing (4) center injection through hole; Connect wire (6) during operation, by being pressed on the therapentic part, hand syringes (3) is carried out drug injection by casing (4) center injection through hole with therapeutic apparatus, has injected rear starting switch (5) friction head and has rotated and can treat.
The Therapeutic Method concrete steps are as follows:
At first syringe is full of medicinal liquid 1-2 milliliter before the treatment, therapeutic apparatus gently is pressed in around the vascular lesion on the infantile myasthenia tissue site, liquid medicine injection, then starting switch rotates friction head, fixing therapeutic device is not mobile during treatment, treatment time is 2-3 minute, and the therapentic part area is about 15 square centimeters, and is similar to the therapeutic apparatus area.After one time has treated at the position can to around up and down the position proceed treatment, liquid medicine injection simultaneously, treatment time was total up to 10 minutes, once a day, be 15 per course for the treatment of.The prior art treatment is proceeded during the treatment, and acute attack stage is in hospitalize, and acute stage can treat later at home.
When varied because of syringe styled, when using the syringe through hole inconvenient, can determine first that the injection site carries out drug injection, inject one square centimeter of big or small adhesive plaster of rear usefulness and covered pinprick, then therapeutic apparatus is placed on the therapentic part, observe adhesive plaster by the injection through hole and determine the therapeutic apparatus center, treatment then rubs.Friction head average distance pinprick place is about 0.7 centimetre like this, can not produce infringement to the pinprick place during rotation.
Embodiments of the invention: early treatment's device of the present invention is by four extrusion friction heads are housed, 1000 rev/mins of rotating speeds, pressure 0.5 kg/cm, product is examined through Shandong Province Drug Administration, obtain No. 2020044 authentication code of Shandong pencil tool (examination) word 2000, in Qingdao Municipal Hospital, Qingdao City institute of traditional Chinese medicine the cerebral infarction disease patient is carried out the several years treatment and try out, treatment cerebral infarction hemiplegia 32 routine clinical observation reports are wherein arranged, conclusion is satisfactory effect.Well received in province's technical products evaluation meeting, this product is filled in application range of products by Shandong Province Drug Administration has therapeutical effect to the cerebral infarction hemiplegia.
Claims (1)
1. cerebral infarction disease therapeutic apparatus, the integral body that it is comprised of extrusion friction head, static friction head, syringe, casing, switch, wire, cerebral infarction disease function reduction diseased region is carried out frictional heat, treats by rubbing up the drug injection restore funcitons, combine the wholistic therapy cerebral infarction disease with the anti-damage medicine symptomatic treatment of prior art; It is characterized in that: extrusion friction head (1) staggered be installed in casing (4) in parallel with static friction head (2), by putting, switch (5) is installed on the casing (4) syringe (3) by casing (4) center injection through hole; Connect wire (6) during operation, by being pressed on the therapentic part, hand syringes (3) is carried out drug injection by casing (4) center injection through hole with therapeutic apparatus, has injected rear starting switch (5) friction head and has rotated and can treat.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104021972A CN102921068A (en) | 2012-10-22 | 2012-10-22 | Cerebral infarction disease therapeutic apparatus |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012104021972A CN102921068A (en) | 2012-10-22 | 2012-10-22 | Cerebral infarction disease therapeutic apparatus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102921068A true CN102921068A (en) | 2013-02-13 |
Family
ID=47636084
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012104021972A Pending CN102921068A (en) | 2012-10-22 | 2012-10-22 | Cerebral infarction disease therapeutic apparatus |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102921068A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101116761A (en) * | 2006-10-31 | 2008-02-06 | 李复生 | Equipment for treating cardiovascular and cerebrovascular diseases |
| CN101120904A (en) * | 2006-11-13 | 2008-02-13 | 李复生 | Therapeutic device for cancer diseases |
| CN201088777Y (en) * | 2007-08-21 | 2008-07-23 | 南京市鼓楼区顺达医疗电子设备厂 | Multifunctional physical medicine-injection treatment head |
| CN202822344U (en) * | 2012-10-22 | 2013-03-27 | 李安 | Cerebral infarction disease treatment device |
-
2012
- 2012-10-22 CN CN2012104021972A patent/CN102921068A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101116761A (en) * | 2006-10-31 | 2008-02-06 | 李复生 | Equipment for treating cardiovascular and cerebrovascular diseases |
| CN101120904A (en) * | 2006-11-13 | 2008-02-13 | 李复生 | Therapeutic device for cancer diseases |
| CN201088777Y (en) * | 2007-08-21 | 2008-07-23 | 南京市鼓楼区顺达医疗电子设备厂 | Multifunctional physical medicine-injection treatment head |
| CN202822344U (en) * | 2012-10-22 | 2013-03-27 | 李安 | Cerebral infarction disease treatment device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103705906B (en) | Chinese medicine hot compress plaster for improving microcirculation and relieving pain | |
| Wang et al. | Progress on integrated Chinese and Western medicine in the treatment of osteoarthritis | |
| CN101797327B (en) | Chinese medicinal preparation for treating pain caused by orthopedic diseases | |
| CN103126866B (en) | Cancer diffusion transfer therapeutic equipment | |
| CN202822344U (en) | Cerebral infarction disease treatment device | |
| CN104095953B (en) | A kind of medicated wine for the treatment of rheumatic osteopathia | |
| CN102552612B (en) | Traditional Chinese medicine for setting fracture | |
| CN101664491A (en) | Medicament for treating arthralgia-synadrome and preparation method thereof | |
| CN202822038U (en) | Cancer diffusion transfer therapeutic instrument | |
| Zhang et al. | Governor vessel moxibustion: Ancient Chinese medical technology with new vitality | |
| CN102921068A (en) | Cerebral infarction disease therapeutic apparatus | |
| CN103239351A (en) | Breast cancer metastasis therapeutic device | |
| CN202822479U (en) | Uremia skin dialysis treatment device | |
| CN102225101B (en) | Traditional Chinese medicine for treating hemorrhoids | |
| CN103263333A (en) | Lung cancer metastasis therapy apparatus | |
| CN204092533U (en) | Hepatoma Metastasis therapeutic apparatus | |
| CN102920576A (en) | Bed body type diabetes therapeutic apparatus | |
| CN104207926B (en) | Hepatoma Metastasis therapeutic apparatus | |
| CN202822036U (en) | Bed body type diabetes mellitus therapeutic appliance | |
| CN101703596B (en) | Medicinal liquor for treating pains and other diseases caused by hyperosteogeny | |
| CN106266361A (en) | A kind of External-applicationChinese Chinese medicinal preparation treating cervical and lumbar diseases | |
| CN100584375C (en) | Formula for treating scar | |
| CN103800874B (en) | A kind of pharmaceutical composition of fumigation treatment apoplexy hemiplegia limbs disturbance | |
| CN101554432B (en) | Fumigating and washing medicine for curing hemorrhoids | |
| CN102961249A (en) | Plan for treating arthralgia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130213 |